难治性-话题@MedSci

#难治性#

683篇内容 | 2682人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1528522, encodeId=1ab5152852219, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Lancet：Erenumab——难治性偏头痛患者的福音, objectType=article, longId=151686, objectId=638b1516864f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=638b1516864f, replyNumber=0, likeNumber=67, createdTime=2018-10-25, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=638b1516864f, moduleTitle=Lancet：Erenumab——难治性偏头痛患者的福音, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=638b1516864f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528521, encodeId=da12152852194, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Lancet Gastroen Hepatol：低剂量丙咪嗪治疗难治性功能性消化不良, objectType=article, longId=151684, objectId=4e55151684ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e55151684ef, replyNumber=0, likeNumber=89, createdTime=2018-10-24, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e55151684ef, moduleTitle=Lancet Gastroen Hepatol：低剂量丙咪嗪治疗难治性功能性消化不良, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4e55151684ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528520, encodeId=8722152852028, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=立体定向手术治疗功能区灰质异位所致难治性癫痫, objectType=article, longId=150765, objectId=11cb150e651c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=11cb150e651c, replyNumber=0, likeNumber=0, createdTime=2018-10-12, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=11cb150e651c, moduleTitle=立体定向手术治疗功能区灰质异位所致难治性癫痫, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=11cb150e651c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528519, encodeId=e85c1528519cf, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Prostate Cancer P D：化疗后转移去势难治性前列腺癌男性在恩杂鲁胺治疗期间，雄激素阻断治疗重要性分析, objectType=article, longId=150382, objectId=a59715038267, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a59715038267, replyNumber=0, likeNumber=74, createdTime=2018-10-07, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a59715038267, moduleTitle=Prostate Cancer P D：化疗后转移去势难治性前列腺癌男性在恩杂鲁胺治疗期间，雄激素阻断治疗重要性分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a59715038267)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528518, encodeId=7b68152851890, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Ann Rheum Dis ：托珠单抗对糖皮质激素难治性成人still病的疗效, objectType=article, longId=150335, objectId=2ffe15033567, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2ffe15033567, replyNumber=0, likeNumber=62, createdTime=2018-10-05, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2ffe15033567, moduleTitle=Ann Rheum Dis ：托珠单抗对糖皮质激素难治性成人still病的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2ffe15033567)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528517, encodeId=a26a152851ec5, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=免疫激活剂ONCOS-102辅助治疗难治性黑色素瘤取得初步结果, objectType=article, longId=149967, objectId=b1e214996ea4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b1e214996ea4, replyNumber=0, likeNumber=51, createdTime=2018-09-30, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b1e214996ea4, moduleTitle=免疫激活剂ONCOS-102辅助治疗难治性黑色素瘤取得初步结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b1e214996ea4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528516, encodeId=c2f3152851610, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=ANN ONCOL：Nintedanib治疗难治性转移性结直肠癌, objectType=article, longId=149951, objectId=509f149951c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=509f149951c3, replyNumber=0, likeNumber=66, createdTime=2018-09-30, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=509f149951c3, moduleTitle=ANN ONCOL：Nintedanib治疗难治性转移性结直肠癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=509f149951c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528515, encodeId=8760152851501, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Blood：泊马度胺联合地塞米松可有效治疗难治性/复发性原发性CNS或玻璃体视网膜淋巴瘤, objectType=article, longId=149948, objectId=038214994893, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=038214994893, replyNumber=0, likeNumber=0, createdTime=2018-09-30, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=038214994893, moduleTitle=Blood：泊马度胺联合地塞米松可有效治疗难治性/复发性原发性CNS或玻璃体视网膜淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=038214994893)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528514, encodeId=b8af1528514a1, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=ANN ONCOL：Venetoclax联合苯达莫司汀-利妥昔单抗治疗复发/难治性非霍奇金淋巴瘤, objectType=article, longId=149945, objectId=ad0014994583, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ad0014994583, replyNumber=0, likeNumber=70, createdTime=2018-09-30, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ad0014994583, moduleTitle=ANN ONCOL：Venetoclax联合苯达莫司汀-利妥昔单抗治疗复发/难治性非霍奇金淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ad0014994583)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528513, encodeId=14511528513f4, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Clin Cancer Res：激光激酶A抑制剂alisertib在去势难治性和神经内分泌前列腺癌患者中的阶段II试验效果和生物标记研究, objectType=article, longId=149764, objectId=f28b149e64db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f28b149e64db, replyNumber=0, likeNumber=53, createdTime=2018-09-29, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f28b149e64db, moduleTitle=Clin Cancer Res：激光激酶A抑制剂alisertib在去势难治性和神经内分泌前列腺癌患者中的阶段II试验效果和生物标记研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f28b149e64db)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528512, encodeId=9291152851297, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=2018 CSCO | 朱军教授：全方位解读CAR-T产品在复发难治性淋巴瘤中的应用现状及前景, objectType=article, longId=149483, objectId=898214948345, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=898214948345, replyNumber=0, likeNumber=0, createdTime=2018-09-25, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=898214948345, moduleTitle=2018 CSCO | 朱军教授：全方位解读CAR-T产品在复发难治性淋巴瘤中的应用现状及前景, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=898214948345)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528511, encodeId=d10015285113d, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=2018 AHA科学声明：难治性高血压的检测，评估和管理, objectType=article, longId=149151, objectId=d4e1149151be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d4e1149151be, replyNumber=0, likeNumber=24, createdTime=2018-09-21, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d4e1149151be, moduleTitle=2018 AHA科学声明：难治性高血压的检测，评估和管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d4e1149151be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528510, encodeId=d7921528510da, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=CLIN CANCER RES：抗ENPP3抗体-药物共轭物治疗晚期难治性肾细胞癌, objectType=article, longId=149142, objectId=f02414914258, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f02414914258, replyNumber=0, likeNumber=66, createdTime=2018-09-21, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f02414914258, moduleTitle=CLIN CANCER RES：抗ENPP3抗体-药物共轭物治疗晚期难治性肾细胞癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f02414914258)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528509, encodeId=efaf15285094d, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Ann Oncol：转移性去势难治性前列腺癌化疗男性患者中，总生存预后模型的建立和研究, objectType=article, longId=148999, objectId=b28a1489990c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b28a1489990c, replyNumber=0, likeNumber=72, createdTime=2018-09-18, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b28a1489990c, moduleTitle=Ann Oncol：转移性去势难治性前列腺癌化疗男性患者中，总生存预后模型的建立和研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b28a1489990c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528508, encodeId=723d1528508a9, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Ann Rheum Dis：难治性类风湿性关节炎的特征, objectType=article, longId=148964, objectId=cc11148964a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cc11148964a4, replyNumber=0, likeNumber=120, createdTime=2018-09-18, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cc11148964a4, moduleTitle=Ann Rheum Dis：难治性类风湿性关节炎的特征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cc11148964a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528507, encodeId=af43152850e26, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Blood：非病毒RNA转导的CART19细胞治疗复发/难治性霍奇金淋巴瘤安全可行, objectType=article, longId=148840, objectId=8e981488405a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8e981488405a, replyNumber=0, likeNumber=24, createdTime=2018-09-15, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8e981488405a, moduleTitle=Blood：非病毒RNA转导的CART19细胞治疗复发/难治性霍奇金淋巴瘤安全可行, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8e981488405a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528506, encodeId=ae8315285061f, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=2018 BSG/HIS指南：粪菌移植治疗复发性难治性艰难梭菌感染以及其他潜在并发症, objectType=article, longId=148088, objectId=59d014808817, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=59d014808817, replyNumber=0, likeNumber=17, createdTime=2018-09-04, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=59d014808817, moduleTitle=2018 BSG/HIS指南：粪菌移植治疗复发性难治性艰难梭菌感染以及其他潜在并发症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=59d014808817)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528505, encodeId=e0471528505a4, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=百济神州宣布中国药监局接受zanubrutinib用于治疗复发/难治性套细胞淋巴瘤的新药申请, objectType=article, longId=147531, objectId=c60e14e531c9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c60e14e531c9, replyNumber=0, likeNumber=70, createdTime=2018-08-29, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c60e14e531c9, moduleTitle=百济神州宣布中国药监局接受zanubrutinib用于治疗复发/难治性套细胞淋巴瘤的新药申请, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c60e14e531c9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528504, encodeId=68951528504d9, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=JCO：中位PFS 25.8月！GA101+苯达莫司汀方案可显著改善难治性惰性NHL患者生存, objectType=article, longId=147021, objectId=15b014e02131, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=15b014e02131, replyNumber=0, likeNumber=69, createdTime=2018-08-21, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=15b014e02131, moduleTitle=JCO：中位PFS 25.8月！GA101+苯达莫司汀方案可显著改善难治性惰性NHL患者生存, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=15b014e02131)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528503, encodeId=aba4152850319, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Lancet oncol：色瑞替尼联合吉西他滨用于原发性难治性或复发性霍奇金淋巴瘤的安全性评估, objectType=article, longId=146860, objectId=713314686070, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=713314686070, replyNumber=0, likeNumber=77, createdTime=2018-08-19, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=713314686070, moduleTitle=Lancet oncol：色瑞替尼联合吉西他滨用于原发性难治性或复发性霍奇金淋巴瘤的安全性评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=713314686070)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

难治性

2020-05-29

freve (审核中...)

前往app查看评论内容

#难治性#

Lancet：Erenumab——难治性偏头痛患者的福音

2018-10-25

freve (审核中...)

前往app查看评论内容

#难治性#

Lancet Gastroen Hepatol：低剂量丙咪嗪治疗难治性功能性消化不良

2018-10-24

freve (审核中...)

前往app查看评论内容

#难治性#

立体定向手术治疗功能区灰质异位所致难治性癫痫

2018-10-12

freve (审核中...)

前往app查看评论内容

#难治性#

Prostate Cancer P D：化疗后转移去势难治性前列腺癌男性在恩杂鲁胺治疗期间，雄激素阻断治疗重要性分析

2018-10-07

freve (审核中...)

前往app查看评论内容

#难治性#

Ann Rheum Dis ：托珠单抗对糖皮质激素难治性成人still病的疗效

2018-10-05

freve (审核中...)

前往app查看评论内容

#难治性#

免疫激活剂ONCOS-102辅助治疗难治性黑色素瘤取得初步结果

2018-09-30

freve (审核中...)

前往app查看评论内容

#难治性#

ANN ONCOL：Nintedanib治疗难治性转移性结直肠癌

2018-09-30

freve (审核中...)

前往app查看评论内容

#难治性#

Blood：泊马度胺联合地塞米松可有效治疗难治性/复发性原发性CNS或玻璃体视网膜淋巴瘤

2018-09-30

freve (审核中...)

前往app查看评论内容

#难治性#

ANN ONCOL：Venetoclax联合苯达莫司汀-利妥昔单抗治疗复发/难治性非霍奇金淋巴瘤

2018-09-30

freve (审核中...)

前往app查看评论内容

#难治性#

Clin Cancer Res：激光激酶A抑制剂alisertib在去势难治性和神经内分泌前列腺癌患者中的阶段II试验效果和生物标记研究

2018-09-29

freve (审核中...)

前往app查看评论内容

#难治性#

2018 CSCO | 朱军教授：全方位解读CAR-T产品在复发难治性淋巴瘤中的应用现状及前景

2018-09-25

freve (审核中...)

前往app查看评论内容

#难治性#

2018 AHA科学声明：难治性高血压的检测，评估和管理

2018-09-21

freve (审核中...)

前往app查看评论内容

#难治性#

CLIN CANCER RES：抗ENPP3抗体-药物共轭物治疗晚期难治性肾细胞癌

2018-09-21

freve (审核中...)

前往app查看评论内容

#难治性#

Ann Oncol：转移性去势难治性前列腺癌化疗男性患者中，总生存预后模型的建立和研究

2018-09-18

freve (审核中...)

前往app查看评论内容

#难治性#

Ann Rheum Dis：难治性类风湿性关节炎的特征

2018-09-18

freve (审核中...)

前往app查看评论内容

#难治性#

Blood：非病毒RNA转导的CART19细胞治疗复发/难治性霍奇金淋巴瘤安全可行

2018-09-15

freve (审核中...)

前往app查看评论内容

#难治性#

2018 BSG/HIS指南：粪菌移植治疗复发性难治性艰难梭菌感染以及其他潜在并发症

2018-09-04

freve (审核中...)

前往app查看评论内容

#难治性#

百济神州宣布中国药监局接受zanubrutinib用于治疗复发/难治性套细胞淋巴瘤的新药申请

2018-08-29

freve (审核中...)

前往app查看评论内容

#难治性#

JCO：中位PFS 25.8月！GA101+苯达莫司汀方案可显著改善难治性惰性NHL患者生存

2018-08-21

freve (审核中...)

前往app查看评论内容

#难治性#

Lancet oncol：色瑞替尼联合吉西他滨用于原发性难治性或复发性霍奇金淋巴瘤的安全性评估

2018-08-19

科室
- - 订阅+
  - 更多科室
工具
服务